eXoZymes: Funding, Investors & Team (Sep 2026)
eXoZymes focuses on creating enzymes and developing enzyme pathways that can function independently outside of living cells, eliminating challenges commonly encountered by other synthetic biology companies when scaling up cell-based or immobilized biomanufacturing methods.
eXoZymes has raised $2.3M across 2 funding rounds on record, the most recent an undisclosed round of $2.0M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
eXoZymes Company Profile and Key Stats
Latest funding round on record: Jun 2026.
eXoZymes Funding Rounds
eXoZymes raised $300k in an undisclosed round announced in Apr 2025.
1.2 years later, an undisclosed round of $2.0M was announced in Jun 2026.
eXoZymes Founders and Leadership Team
Contact details for the eXoZymes team: 1 of 2 have an email address on file.
Start 14-day free trial →eXoZymes Funding Compared to Other Biotechnology Startups
eXoZymes' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like eXoZymes in Biotechnology and Monrovia
Companies Similar to eXoZymes
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
eXoZymes Funding FAQs
What does eXoZymes do?
eXoZymes focuses on creating enzymes and developing enzyme pathways that can function independently outside of living cells, eliminating challenges commonly encountered by other synthetic biology companies when scaling up cell-based or immobilized biomanufacturing methods.
How much funding has eXoZymes raised?
eXoZymes has raised $2.3M across 2 rounds on record. The most recent is an undisclosed round of $2.0M announced in Jun 2026.
When did eXoZymes last raise funding?
eXoZymes' most recent funding round on record is an undisclosed round of $2.0M, announced in Jun 2026.
Who founded eXoZymes?
FundedIQ lists Michael Heltzen (Founder), Paul Opgenorth (Founder) at eXoZymes.
Where is eXoZymes headquartered?
eXoZymes is based in Monrovia, California, United States.
How many employees does eXoZymes have?
eXoZymes is in the 11-50 employee band.
How does eXoZymes' funding compare to other Biotechnology startups?
eXoZymes' latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's eXoZymes Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for eXoZymes is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.